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Mucosal-associated invariant T (MAIT) cells are 
an evolutionarily conserved (Tilloy et al., 1999; 
Huang et al., 2009) innate-like population of 
T cells that are very abundant in humans (Porcelli 
et al., 1993; Tilloy et al., 1999; Reantragoon 
et al., 2012). MAIT cells have been implicated 
in protective and aberrant immunity, but their 
specific function remains obscure (Illés et al., 
2004; Croxford et al., 2006; Peterfalvi et al., 
2008; Godfrey et al., 2010; Gold et al., 2010; 
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Mucosal-associated invariant T (MAIT) cells express an invariant T cell receptor (TCR) 
-chain (TRAV1-2 joined to TRAJ33, TRAJ20, or TRAJ12 in humans), which pairs with an 
array of TCR -chains. MAIT TCRs can bind folate- and riboflavin-based metabolites re-
stricted by the major histocompatibility complex (MHC)-related class I−like molecule, MR1. 
However, the impact of MAIT TCR and MR1-ligand heterogeneity on MAIT cell biology is 
unclear. We show how a previously uncharacterized MR1 ligand, acetyl-6-formylpterin 
(Ac-6-FP), markedly stabilized MR1, potently up-regulated MR1 cell surface expression, 
and inhibited MAIT cell activation. These enhanced properties of Ac-6-FP were attributable 
to structural alterations in MR1 that subsequently affected MAIT TCR recognition via 
conformational changes within the complementarity-determining region (CDR) 3 loop. 
Analysis of seven TRBV6-1+ MAIT TCRs demonstrated how CDR3 hypervariability impacted 
on MAIT TCR recognition by altering TCR flexibility and contacts with MR1 and the Ag 
itself. Ternary structures of TRBV6-1, TRBV6-4, and TRBV20+ MAIT TCRs in complex with 
MR1 bound to a potent riboflavin-based antigen (Ag) showed how variations in TRBV gene 
usage exclusively impacted on MR1 contacts within a consensus MAIT TCR-MR1 footprint. 
Moreover, differential TRAJ gene usage was readily accommodated within a conserved 
MAIT TCR-MR1-Ag docking mode. Collectively, MAIT TCR heterogeneity can fine-tune MR1 
recognition in an Ag-dependent manner, thereby modulating MAIT cell recognition.
© 2014 Eckle et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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sequestered by an aromatic cradle within MR1, whereupon 
some of the ligands can form a covalent bond (Schiff base) 
with MR1 (Kjer-Nielsen et al., 2012). Although the 6-FP 
ligand up-regulated MR1 cell surface expression, it did not 
stimulate MAIT cells (Kjer-Nielsen et al., 2012). However, 
the ribityllumazines were stimulatory, with the extent of MAIT 
cell potency varying markedly, such that synthetic rRL-6-
CH2OH (reduced 6-hydroxymethyl-8-d-ribityllumazine) is 
1,000 times more potent than the weak agonists RL-6,7-
DiMe and RL-6-Me-7-OH (Kjer-Nielsen et al., 2012). We 
recently traced the high potency of rRL-6-CH2OH to MR1 
trapping and presentation of a relatively unstable pyrimidine-
based transitory derivative (5-OP-RU), with similar high 
potency also found for a homologue with one carbon less 
(5-OE-RU) but no activity for another homologue with one 
extra carbon, 5-(1-methyl-2-oxopropylideneamino)-6-d- 
ribitylaminouracil (5-MOP-RU; Corbett et al., 2014). Thus, 
the MR1 cleft, although having a penchant for small mole-
cule uracil derivatives, nonetheless has sufficient plasticity to 
accommodate a range of chemical entities, but the nature and 
relative impact of molecular determinants on MR1 function 
remains underexplored.
We recently provided insight into how the human TRAV1-
2-TRAJ33-TRBV6-1+ MAIT TCR recognized human MR1 
presenting 6-FP, RL-6-Me-7-OH (Patel et al., 2013) and two 
short lived adducts, 5-OE-RU and 5-OP-RU, arising from 
reaction of glyoxal and methylglyoxal, respectively, with 
5-amino-6-d-ribitylaminouracil (5-A-RU), an intermediate in 
bacterial riboflavin synthesis (Corbett et al., 2014). Regardless 
of the stimulatory properties of the ligand, the MAIT TCR 
docked in a conserved manner with MR1 (Patel et al., 2013; 
Corbett et al., 2014), with this consensus docking mode being 
observed in a humanized bovine MR1-MAIT TCR ternary 
complex with undefined Ags bound (López-Sagaseta et al., 
2013). The important role of the MAIT TCR -chain was 
underpinned by the marked effect some residues had on 
MR1-Ag recognition. In contrast, the germline-encoded re-
gions of the TCR -chain appeared less ideally disposed to 
interact with MR1, which was consistent with an alanine-
scanning mutagenesis study on the human MAIT TCR 
TRBV6-1 encoded region (Reantragoon et al., 2012). Nev-
ertheless, the CDR3 loop interacted extensively with MR1, 
being situated directly above the Ag itself, thereby suggesting 
that CDR3 loop hypervariability may impact on MAIT 
TCR recognition in an Ag-dependent manner. MR1 tetramers 
loaded (Reantragoon et al., 2013) or refolded (Corbett et al., 
2014) with the transitory intermediates stained the majority 
of MAIT cells, suggesting that MAIT cells, regardless of their 
MAIT TCR repertoire, are tailored to interact with potent 
Ags, in a manner analogous to how the CD1d-restricted ligand 
-galactosylceramide represents the universal potent ligand 
for NKT cells (Matsuda et al., 2000). However, it is unknown 
whether less potent MAIT cell Ags are recognized differentially 
on account of variations in the MAIT TCR repertoire, as ob-
served in NKT cell recognition of weak agonists (Pellicci 
et al., 2009; Matulis et al., 2010; Wun et al., 2011).
Le Bourhis et al., 2010; Miyazaki et al., 2011; Chua et al., 2012; 
Eckle et al., 2013; Gold and Lewinsohn, 2013; Meierovics 
et al., 2013; Birkinshaw et al., 2014; Serriari et al., 2014). Once 
activated via their  TCR, MAIT cells rapidly secrete an array 
of cytokines (Kawachi et al., 2006; Dusseaux et al., 2011; Tang 
et al., 2013). Unlike the classical MHC-restricted T lympho-
cytes, MAIT cells typically express an invariant TCR -chain 
paired with one of a selected group of TCR -chains, with 
the MAIT TCR being highly conserved across mammals 
(Tilloy et al., 1999; Huang et al., 2009). In humans, the TCR 
-chain comprises the TRAV1-2 gene that combines with 
the TRAJ33 gene segment, with limited nonnucleotide (N) 
additions/deletions at the TRAV1-2-TRAJ33 junction. In 
mice, the MAIT TCR repertoire uses the orthologous TCR 
-chain (TRAV1-TRAJ33). In addition, the human MAIT 
TCR -chain repertoire also includes smaller subsets con-
taining TRAJ20 and TRAJ12 gene segments paired with the 
TRAV1-2 gene (Reantragoon et al., 2013). Although the 
human MAIT TCR -chain repertoire was considered to 
mainly be comprised of TRBV20, TRBV6-1, and TRBV6-4 
genes (Tilloy et al., 1999), MR1-tetramer based studies have 
demonstrated that the MAIT TCR -chain repertoire is 
more diverse (Reantragoon et al., 2013). Moreover, the MAIT 
TCR -chain is typified by a hypervariable complementarity-
determining region (CDR) 3 loop (Tilloy et al., 1999; 
Reantragoon et al., 2013). The semiinvariant nature of the 
MAIT TCR resonates with the repertoire diversity of type I 
NKT TCRs (Borg et al., 2007; Mallevaey et al., 2009; Pellicci 
et al., 2009; Patel et al., 2011; Rossjohn et al., 2012). However, 
although we have a growing understanding of how the NKT 
TCR repertoire can interact with a range of CD1d-restricted, 
lipid-based Ags, the molecular basis of MAIT TCR - and 
-chain heterogeneity, CDR3 hypervariability, and MR1-
ligand diversity on MAIT cell function is unknown.
The MAIT TCR is restricted by the MHC class I–related 
molecule MR1 (Treiner et al., 2003; Huang et al., 2005; 
Huang et al., 2008). MR1 is a monomorphic Ag-presenting 
molecule that is highly conserved across mammals (Tsukamoto 
et al., 2013). Although the MR1 transcript is expressed widely 
(Hashimoto et al., 1995; Riegert et al., 1998), cell surface ex-
pression of MR1 is very low/absent, thereby indicating that 
other factors, including Ag supply, can determine the level of 
MR1 that egresses to the cell membrane (Huang et al., 2008; 
Chua et al., 2011). Recently, it has been established that MR1 
can bind vitamin B–based precursors and derivatives that orig-
inate from folic acid (vitamin B9) and riboflavin (vitamin B2) 
biosynthesis (Kjer-Nielsen et al., 2012). Specifically, MR1 can present 
6-formylpterin (6-FP), a naturally occurring photo-degradation 
product of folic acid, and a series of ribityllumazines, including 
6,7-dimethyl-8-d-ribityllumazine (RL-6,7-DiMe), 6-methyl-
7-hydroxy-8-d-ribityllumazine (RL-6-Me-7-OH; Kjer-Nielsen 
et al., 2012; Patel et al., 2013), 5-(2-oxoethylideneamino)-6-d- 
ribitylaminouracil (5-OE-RU), and 5-(2-oxopropylideneamino) 
-6-d-ribitylaminouracil (5-OP-RU; Corbett et al., 2014). 
The MR1 Ag-binding cleft is ideally disposed to bind to 
these small organic metabolites, with the ligands being closely 
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competitively inhibit MAIT cell recognition more potently. 
Although the compounds 6,7-dimethylpterin, 6-hydroxymethyl-
pterin, pterin, l-monapterin, tetrahydrobiopterin, xanthop-
terin, and pterin-6-carboxylic acid (Fig. 1 a) could not be 
refolded with MR1 or increase MR1 cell surface expression, 
acetyl-6-FP (Ac-6-FP) readily refolded with MR1 as judged 
by gel filtration profile and cell staining with the MR1-reactive 
mAb 26.5 (not depicted). Analogous to MR1-6-FP tetramers, 
MR1–Ac-6-FP tetramers did not stain human PBMCs (Fig. 1 b), 
which is indicative of Ac-6-FP not representing a stimulating 
ligand for MAIT cells. Ac-6-FP differs from 6-FP by the pres-
ence of an acetyl group (Fig. 1 a), yet it still possesses a formyl 
group at the 6-position and thus was anticipated to form a 
Schiff base when bound to MR1. Ac-6-FP caused much 
greater surface up-regulation of MR1 when compared with 
In this study, we address the impact of MAIT TCR het-
erogeneity on recognition of different MR1-restricted ligands. 
Although the MAIT TCR heterogeneity converged onto a 
common docking footprint on MR1, we show that TCR 
-chain usage can modulate MAIT TCR recognition and 
fine-tune the response in an Ag-dependent manner.
RESULTS
A novel MAIT cell inhibitory ligand
We previously established that 6-FP could up-regulate MR1 
cell surface expression on C1R.MR1 cells without activating 
MAIT cells or Jurkat cells transduced with a MAIT TCR 
( Jurkat.MAIT; Kjer-Nielsen et al., 2012). Instead, 6-FP was a 
weak competitive antagonist of MAIT cell activation (Patel et al., 
2013). Thus, we evaluated whether analogues of 6-FP could 
Figure 1. MR1 tetramer staining and 
MR1 up-regulation by 6-FP and Ac-6-FP. 
(a) Chemical structures of MR1-restricted 
pterin ligands (6-FP [6-FP, i] and acetyl-6-FP 
[Ac-6-FP, ii]) and pterin-based compounds 
that did not bind to MR1 (pterin [iii], 6,7-
dimethylpterin [6,7-diMePterin, iv], xanthop-
terin [v], pterin-6-carboxylic acid [vi], 
6-hydroxymethylpterin [6-OHMePterin, vii], 
l-monapterin [viii], tetrahydrobiopterin [ix]). 
(b) Human PBMCs were stained with CD3- 
and CD161-specific mAbs and human tetra-
meric MR1–5-OP-RU, MR1-6-FP, or MR1– 
Ac-6-FP, respectively. Live, CD3+ cells were 
considered for CD161 (x axis) and tetramer 
staining (y axis), displaying dot plots and per-
centages of cells within boxed regions. Displayed 
are the results of three representative of 6 
healthy blood donors tested. These experi-
ments were performed twice using two inde-
pendent batches of tetramer and yielding similar 
results. (c) MR1 expression levels on C1R.MR1 
cells upon incubation with 6-FP, Ac-6-FP,  
6,7-dimethylpterin, 6-hydroxymethylpterin,  
and 5-OP-RU added in indicated doses and 
for indicated time spans. Cells were stained 
with anti-MR1 mAb 26.5. Data shows MFI fold 
of background of MR1 expression levels, 
mean ± SEM of three independent experi-
ments done in triplicates. These experiments 
were performed three times, yielding similar 
results and a representative experiment is 
shown. (d) Comparison of MR1 expression 
levels on C1R and C1R.MR1 cells upon incu-
bation with 10 µM 6-FP or Ac-6-FP, or without  
ligand (media), for different time periods.  
Cells were stained with anti-MR1 mAb 26.5. 
Data shows untransformed geometric MFI 
(gMFI) of MR1 expression levels for each time 
point. Mean ± SEM of triplicates. These  
experiments were performed twice, yielding 
similar results and a representative experi-
ment is shown.
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these values to the half maximum melting temperatures 
(Tm50) of recombinant MR1-6-FP, MR1–5-OP-RU, MR1-
K43A-5-OP-RU, and MR1-K43A (empty; Fig. 2 c). The 
MR1-K43A protein, in which the Lys43 had been mutated 
to alanine to prevent Schiff base formation with any ligands 
(Reantragoon et al., 2013) was refolded in the absence of any 
ligands. This MR1-K43A empty molecule had a Tm50 of 
40°C and served as the baseline to assess the impact of the ef-
fect of Schiff base formation and the presence of ligand on 
MR1 stability. Notably, although MR1-K43A-5-OP-RU ex-
hibited a moderately increased stability (Tm50 46°C) to that of 
MR1-K43A, MR1–5-OP-RU had a markedly increased 
Tm50 value of 63°C. Thus, the ability of 5-OP-RU to form 
6-FP or other pterin-based compounds (Fig. 1 c). Interestingly, 
both ligands induced increased MR1 expression, but the up-
regulation induced by 6-FP was slower and less pronounced 
than that caused by Ac-6-FP. Intriguingly, the effect of 6-FP 
was also transient, whereas it was maintained for at least 24 h 
with Ac-6-FP (Fig. 1 d). Ac-6-FP, although nonstimulatory 
for MAIT cells, nevertheless strongly inhibited Jurkat.MAIT 
activation in response to an agonist ligand, being a 100 fold 
more potent inhibitor than 6-FP in cell-based assays, in which 
CD69 up-regulation and IL-2 production were used as func-
tional readouts (Fig. 2, a and b). To formally test the apparent 
stabilizing effect of Ac-6-FP, we undertook thermostability 
assays on the refolded MR1–Ag complex, and compared 
Figure 2. MAIT cell inhibitory ligands and MR1 
stability. (a) Inhibition of Jurkat.MAIT (original WT, clone 
A-F7) cell activation by 6-FP or Ac-6-FP. 6-FP, Ac-6-FP 
(or controls – 6,7-diMePterin or no ligand) were added to 
C1R.MR1 cells at the indicated concentrations for 1 h 
before addition of Jurkat.MAIT cells and 0.02 µM syn-
thetic rRL-6-CH2OH. Data shows MFI of CD69 expression 
levels for gated Jurkat.MAIT cells. Mean ± SEM of tripli-
cates. These experiments were performed twice, yielding 
similar results and a representative experiment is shown. 
(b) Inhibition of Jurkat76.MAIT (original WT TCR, clone  
A-F7) cell activation by 6-FP or Ac-6-FP. 6-FP, Ac-6-FP 
(or controls, PBS or no ligand) were added to C1R.MR1 
cells at the indicated concentrations and co-incubated with 
Jurkat76.MAIT cells and 0.02 µM synthetic rRL-6-CH2OH.  
Data shows emission at 492 nm correlating with IL-2 
production. These experiments were performed three 
times, showing mean ± SD. (c) Thermostability of soluble 
MR1-ligand by fluorescence-based thermal shift assay. 
Shown is baseline-corrected, normalized emission at  
610 nm plotted against temperature. Mean ± SEM of 
triplicate samples, and nonlinear curve-fits. The half 
maximum melt point (Tm50) is indicated as a dashed line. 
Displayed is a representative of three independent  
experiments yielding similar results. The table  
summarizes the data of three independent experiments, 
each in triplicate.
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at the base of the cleft (Fig. 3 b). Although the overall confor-
mation of the Ag-binding cleft of MR1 was not appreciably 
altered in accommodating Ac-6-FP when compared with 6-FP 
(root mean square deviation (RMSD) of 0.23 Å between MR1-
6-FP and MR1–Ac-6-FP over C atoms within the 1 and 
2 domains), the presence of the additional moiety did cause 
conformational changes within the vicinity of the MR1-
binding pocket. Namely, to accommodate the acetyl group, 
Trp69 was repositioned slightly (0.9 Å displacement of N1), 
Tyr152 was moved away (1.1 Å displacement of OH), and the 
buried residue, Gln153, was repositioned (2.6 Å displacement 
of C) such that its side chain was orientated away from the 
binding pocket (Fig. 3, c and d). This reorientation of Gln153 
caused an altered conformation of Glu149 (2.2 Å displacement 
of C; Fig. 3 c), a surface-exposed MR1 residue that contacts 
the MAIT TCR (discussed below). Thus, subtle plasticity 
within the MR1-Ag–binding cleft allowed for ready accom-
modation of the acetyl group, with these additional contacts 
correlating with 8°C increase in the stability of MR1–Ac-6-
FP in comparison to MR1-6-FP (Fig. 1 c). Moreover, these 
conformational changes affected the conformation of buried 
residues within the MR1-binding pocket that were transmit-
ted to the MAIT TCR-MR1 contact zone.
The TRBV6-1+ MAIT TCR docked onto MR1-6-FP and 
MR1–Ac-6-FP (RMSD 0.25 Å over all C atoms and buried 
surface area [BSA] of 1,100 and 1,210 Å2, respectively) in a 
similar manner. Namely, the MAIT TCR docked orthogo-
nally and centrally over the MR1-Ag–binding cleft, where 
Tyr95 of the TRAJ33 chain contacted the 1 and 2 helices 
of MR1 (Fig. 3 d), whereas the germline-encoded TRBV6-1 
region contacted the 1 helix of MR1 only (not depicted). 
a Schiff base with MR1 resulted in a 17°C increase in MR1 
stability. In contrast, the Tm50 of MR1-6-FP was 56°C, indi-
cating that the stabilizing effect of the Schiff base formation is 
also dependent on the nature of the bound ligand. Interest-
ingly, MR1–Ac-6-FP exhibited a Tm50 value of 64°C, 
suggesting that the presence of the acetyl group in Ac-6-FP 
led to an 8°C increase in stability compared with MR1-6-FP. 
The higher stability of MR1–Ac-6-FP was consistent with 
Ac-6-FP being a more potent inhibitor than 6-FP and having 
a prolonged effect on cell surface expression of MR1.
MAIT TCR-MR1–Ac-6-FP interaction
To understand the impact of the Ac-6-FP ligand, we expressed 
and refolded the TRBV6-1+ MAIT TCR (original WT; clone 
A-F7; Tilloy et al., 1999), added it to refolded MR1–Ac-6-FP, 
crystallized the ternary complex, and solved its structure to 
2.0 Å resolution to an Rfac and Rfree of 18.0 and 22.0%, respec-
tively (Table S1). The electron density at the MAIT TCR-
MR1-Ag interface, and for the ligand itself, was unambiguous 
(Fig. 3 a), thereby permitting a direct comparison to the cor-
responding MAIT TCR-MR1-6-FP structure.
The Ac-6-FP ligand was bound within the MR1 aromatic 
cradle in the same orientation to that observed with 6-FP, 
thereby indicating that the inhibitory property of Ac-6-FP 
was not attributable to differences manifested by altered Ac-
6-FP docking within MR1 (Fig. 3 b). As such, the formyl group 
of Ac-6-FP formed a Schiff base with Lys43, whereas the 
pterin ring was sandwiched between Tyr7, Tyr62, Trp69, and 
Trp156 (Fig. 3 b). The acetyl moiety formed van der Waals 
(vdw) interactions with Tyr152, Trp156, and Ile96, with the 
carbonyl moiety hydrogen bonding to Arg94, which is located 
Figure 3. MAIT TCR recognition of 
MR1–Ac-6-FP. (a) Electron density of  
Ac-6-FP in omit and final 2Fo-Fc maps of the 
ternary complex MR1–Ac-6-FP-MAIT original 
WT (clone A-F7) TCR. Electron density in mesh 
format, the ligand in ball and stick, MR1 in 
ribbon representation in white, a Fo-Fc omit 
map contoured at 3 (green). (b–d) Structural 
basis for Ac-6-FP recognition by MR1 and 
original WT (clone A-F7) MAIT TCR compared 
with the previously published MR1-6-FP orig-
inal WT (clone A-F7) MAIT TCR structure (PDB 
accession no. 4L4T). (b) Superposition of  
Ac-6-FP and 6-FP and MR1 induced confor-
mational changes. (c) CDR3 conformational 
changes induced by Ac-6-FP. (d) Contacts 
between Ac-6-FP and Tyr95 from the 
CDR3 loop. MR1-6-FP residues are shown in 
white, pale yellow, and pale orange for the 
CDR3 and CDR3 loops, respectively, and 
the 6-FP ligand is shown in cyan. Equivalent 
residues from the MR1–Ac-6-FP shown in 
slate, yellow, and orange for the CDR3 and 
CDR3 loops, respectively and Ac-6-FP in 
green with contacts between TCR and  
Ac-6-FP indicated by dashed lines.
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WT TCR (Tilloy et al., 1999; clone A-F7; described previously 
[Reantragoon et al., 2012]). Although exhibiting some minor 
differences in the N-region usage at the TRAV1-2-TRAJ33 
junctional boundaries, the TCRs principally differed in their 
CDR3 composition (Table 1). These 7 MAIT TCRs were 
chosen because they had limited sequence identity within the 
CDR3 loops and differed in sequence length (11–13 aa), 
thereby permitting a broad perspective on CDR3 hyper-
variability on MAIT TCR recognition.
The seven TRBV6-1+ MAIT TCRs were expressed, re-
folded and, as judged by chromatographic profiles, assessed 
to be fully folded. Initially, we undertook surface plasmon 
resonance (SPR)–based studies to measure the binding affin-
ity against MR1–5-OP-RU and MR1–Ac-6-FP (Table 2 
and Fig. 4, a–k).  The A-F7 WT Kdeq for MR1–5-OP-RU 
was 2.0 µM, consistent with previous measurements (Patel 
et al., 2013). The Kdeq values for the remaining six TRBV6-
1+ TCRs toward MR1–5-OP-RU were mostly similar 
(Table 2), thereby providing insight into why MR1 tetramers 
of this ligand effectively stain all MAIT cells (Reantragoon 
et al., 2013; Corbett et al., 2014). Nevertheless, some MAIT 
TCRs (e.g., B-F3-C1) bound more weakly (approximate 
Kdeq = 9.1 µM) in comparison to the A-F7 WT value, whereas 
the B-C10 TCR showed moderately improved binding 
(approximate Kdeq = 0.5 µM) to the MR1–5-OP-RU complex 
(Table 2). Interestingly, great variation in relative binding 
affinities was observed against the MR1–Ac-6-FP complex 
(Fig. 4 a and Table 2). For example, the B-C10 TCR showed 
a marked preference for MR1–Ac-6-FP (approximate Kdeq = 
35.4 µM) in comparison to the other TRBV6-1+ TCRs 
(Kdeq > 200 µM). Accordingly, the CDR3 loop can modu-
late the affinity toward MR1-restricted ligands. A MAIT 
TCR with a high affinity for MR1–Ac-6-FP seems rare, 
however, as we did not observe MR1–Ac-6-FP tetramer+ 
PBMCs (Fig. 1 b).
Interestingly, although the CDR3 loop was of identical se-
quence within these ternary complexes, their respective con-
formations were different, and this was attributable to Ac-6-FP 
induced conformational changes (Fig. 3 c). The CDR3 loop, 
which made an extensive interface with MR1–Ac-6-FP 
(BSA 24%), bridged the 1 and 2 helices of MR1 and was 
directly positioned over the Ag-binding pocket (Fig. 3 c). The 
Ac-6-FP–induced reorientation of Glu149 caused a marked 
remolding of a major region of the CDR3 loop so as to 
prevent the electrostatic repulsion of the remodeled Glu149 
with Glu99, which swung down (6.3 Å displacement of C) 
to slot in between Trp69 and Tyr152 of MR1 (Fig. 3 c). No-
tably, the remodeling of Glu99 also resulted in a subtle, al-
beit important conformational change within the CDR3 
loop. Namely, Glu99 “pulled” Tyr95 toward the ligand, en-
abling it, together with Glu99 from the CDR3 loop back-
bone, to form direct interactions with the nonstimulatory 
ligand (Fig. 3, c and d). These direct contacts with the Ac-6-FP 
are in contrast to the TRBV6-1+ MAIT TCR-MR1-6-FP 
ternary complex in which no direct contacts were observed 
between 6-FP and the TCR (Fig. 3 d). Thus, an MR1-restricted 
ligand can cause conformational changes to the MR1-binding 
cleft that are transmitted to the MAIT TCR, which subse-
quently leads to the hypervariable CDR3 loop making di-
rect contacts with the Ag itself.
Impact of CDR3 variability on MAIT TCR recognition
Given that the CDR3 loop played a prominent and central 
role in interacting with MR1, and the conformation of the 
CDR3 loop could be altered indirectly in an Ag-dependent 
manner, we asked whether CDR3 loop hypervariability 
could impact on MAIT TCR-MR1-Ag recognition. To es-
tablish this, we selected six TRBV6-1+ MAIT TCRs, termed 
B-B10, B-F3-C1, B-G8, B-C10, C-C10, and C-A11, from 
published sequence data (Tilloy et al., 1999) and the original 
Table 1. MAIT TCR usage and sequences
TCR (name) TRAJ CDR3 TRBJ TRBV CDR1 CDR2 CDR3
WT (A-F7) 33 89AVKDSNYQLI98 2-2 6-1 27MNHNS31 49SASEGT54 92ASSVWTGEGSGELF105
B-B10 33 89AGMDSNYQLI98 1-5 6-1 27MNHNS31 49SASEGT54 92ASTLGQEGQPQH103
B-F3-C1 33 89ASIDSNYQLI98 2-2 6-1 27MNHNS31 49SASEGT54 92ASSETDPNTGELF104
B-G8 33 89AAMDSNYQLI98 2-2 6-1 27MNHNS31 49SASEGT54 92ASSGGDSGELF102
B-C10 33 89AAEDSNYQLI98 2-6 6-1 27MNHNS31 49SASEGT54 92ASSYEVSGANVLT104
C-C10 33 89AVVDSNYQLI98 2-3 6-1 27MNHNS31 49SASEGT54 92ASSPPGGTDTQ*Y103
C-A11 33 89AVRDSNYQLI98 1-3 6-1 27MNHNS31 49SASEGT54 92ASSAAVEGGNTIY104
#1 12 89AVMDSSYKLI98 2-1 6-4 27MRHNA31 49SNTAGT54 92ASSRGDYNEQF102
#2 12 89AVMDSSYKLI98 2-1 6-4 27MRHNA31 49SNTAGT54 92ASSASGGAYNEQF104
#3 12 89AVMDSSYKLI98 2-3 6-4 27MRHNA31 49SNTAGT54 92ASSPGTSGGADTQY105
#4 20 89AVRDGDYKLS98 2-2 6-4 27MRHNA31 49SNTAGT54 92ASSAGASTGELF103
#5 33 89AVSDSNYQLI98 2-2 6-4 27MRHNA31 49SNTAGT54 92ASSDSGGGTGELF104
#6 33 89AVMDSNYQLI98 2-1 6-4 27MRHNA31 49SNTAGT54 92ASSGGTNNEQF102
C-F7 33 89AFMDSNYQLI98 2-1 20 27DFQATT32 50SNEGSKA56 95SARTSGDFGEQF107
J segments as part of the CDR regions are shown in italics; N regions (known for sequences reported here (MAIT #1-5) or previously (MAIT #6; Reantragoon et al., 2012) are 
shown in bold. Sequence numbering is indicated. *, Q in TRBJ2-3 but R in Tilloy et al. (1999).
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C-C10 and B-G8 TCRs contributing the least (Figs. 5, a–g). 
The CDR3 loops that are relatively rich in glycine resi-
dues result in a reduced number of CDR3-MR1 contacts, 
while the B-C10 and the A-F7 WT MAIT TCR possess an aro-
matic residue (Tyr and Trp, respectively, Figs. 5, a and c) that 
made conserved interactions with MR1. Further, although 
there is little/no sequence identity between the CDR3 
loops, a negatively charged residue (Asp/Glu) within this loop 
(Table 1) converged to a similar position at the interface in 
four of the seven MAIT TCRs, with the Asp/Glu residue neigh-
boring Tyr95 from the CDR3 loop.
In all the MAIT TCR-MR1-Ac-6-FP ternary complexes, 
the additional acetyl moiety caused Gln153 to swing away, 
which subsequently displaced Tyr152, which caused an al-
tered position of Tyr95 from the CDR3 loop such that it 
now directly contacts the Ac-6-FP antigen (Fig. 3 d and not 
depicted). Thus, the ability of Ac-6-FP to contact the MAIT 
TCR appears to be an intrinsic feature of the ligand itself and 
independent of CDR3 sequence variation. Interestingly, the 
CDR3 loop was also observed to directly contact the Ag, 
with the acidic residue in the original WT (A-F7), B-B10 and 
C-A11 MAIT TCRs (Figs. 5, a–c) directly interacting with 
the acetyl moiety of Ac-6-FP. However, direct CDR3–Ag 
interactions do not necessarily correlate with improved bind-
ing affinities for this ligand, as the B-C10 MAIT TCR was 
observed to have the highest affinity for the MR1-Ac-6-FP 
complex, indicating that other factors, such as CDR3 flexi-
bility can play an important role in the energetics of the 
MAIT TCR-MR1-Ag interaction.
As the CDR3 loop can differently interact with MR1–
Ac-6-FP, we next asked whether this loop would show altered 
flexibility in binding a different ligand, namely MR1–5-OP-
RU. Accordingly, we determined the structures of the B-B10, 
To establish whether the differences in affinity for MR1–
5-OP-RU between the B-F3-C1 MAIT TCR and a high- 
affinity MAIT TCR (B-G8) impacted on functional outcome, 
we transduced the B-F3-C1 and B-G8 MAIT TCRs into the 
SKW3 T cell line (SKW3.B-F3-C1 and SKW3.B-G8). We 
then assessed their ability to be activated by synthetic rRL-6-
CH2OH and 5-A-RU in the presence of C1R.MR1 cells and 
compared activation to the previously transduced SKW3.MAIT 
TCR (WT, clone A-F7; Fig. 4, l and m). Notably, the SKW3.B-
F3-C1 showed reduced activation by synthetic rRL-6-CH2OH 
and 5-A-RU when these ligands were not used at saturating 
concentrations, thereby providing further supporting evidence 
for the CDR3 loop fine-tuning MAIT TCR reactivity.
Next, we sought a structural basis for the observed effects 
of CDR3 impacting on MAIT TCR-MR1-Ag recognition. 
To establish this, we determined the structures of the B-B10, 
B-F3-C1, B-G8, B-C10, C-C10, and C-A11 MAIT TCRs in 
complex with MR1–Ac-6-FP and compared them to the 
original WT (clone A-F7) MAIT TCR MR1–Ac-6-FP ter-
nary complex (Table S1 and Fig. 5, a–g). All seven TRBV6-1+ 
MAIT TCRs sat similarly onto MR1–Ac-6-FP, thereby indi-
cating that the variations within the CDR3 loop do not 
impact on MAIT TCR-MR1 docking. Moreover, with the 
exception of the CDR3 loop-mediated contacts, the major-
ity of the MAIT TCR-MR1 interatomic contacts did not alter 
appreciably, thereby indicating that variations within the 
CDR3 loop are not transferrable to the invariant MAIT 
TCR  chain (with the exception of Tyr95, discussed 
below). While the CDR3 loops were similarly disposed atop 
MR1–Ac-6-FP, the extent of contacts varied between the 
seven TRBV6-1+ MAIT TCRs (BSA values ranging from 15 
to 24%), with the CDR3 loop of the original WT (clone 
A-F7) TCR contributing greatest to the interface and the 
Table 2. Summary of SPR affinities and MAIT cell activation status
MAIT TCR TRAJ TRBV Kdeq (M), mean duplicate 
MR1–5-OP-RU
Activation by 
MR1–5-OP-RU
Kdeq (M), mean duplicate 
Ac-6-FP
Original WT (A-F7) 33 6-1 2.0 ± 0.6 + >200
B-B10 33 6-1 4.2 ± 0. 6 ND >200
B-C10 33 6-1 0.5 ± 0.1 ND 35.4 ± 3.0
C-A11 33 6-1 4.2 ± 0. 5 ND >200
C-C10 33 6-1 2.2 ± 0.3 ND >200
B-G8 33 6-1 1.4 ± 0.2 + >200
B-F3-C1 33 6-1 9.1 ± 1.0 + >200
#1 12 6-4 1.5 ± 0.1 + >200
#2 12 6-4 2.2 ± 0.2 + >200
#3 12 6-4 1.9 ± 0.2 + >200
#1 Y95F 12 6-4 35 ± 2 - >200
#2 Y95F 12 6-4 20 ± 1 - >200
#3 Y95F 12 6-4 33 ± 2 - >200
#4 20 6-4 2.4 ± 0.4 + >200
#6 33 6-4 2.7 ± 0.7 +a N/D
C-F7 33 20 1.0 ± 0.3 +a N/D
a5-OP-RU presented by C1R.MR1 incubated with MAIT cell–activating bacteria (Reantragoon et al., 2012) or rRL-6-CH2OH (Patel et al., 2013).
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of the main chain of the CDR3 loop (RMSD 0.43 Å over C 
atoms). Interestingly, although the CDR3 loop of the C-C10 
TCR did not directly contact Ac-6-FP, within the C-C10 
TCR-MR1–5-OP-RU ternary complex, this loop was drawn 
toward the ligand (6.5 Å displacement of Gly97 O), implying 
a greater degree of flexibility in the C-C10 CDR3 loop 
(Fig. 6 b). The movement of the CDR3 loop enabled its 
main chain to directly contact the ribityl group of 5-OP-RU 
through Gly97, which itself exhibited some flexibility in that 
it reoriented its aliphatic moiety (not shown) to enable favor-
able contacts with the CDR3 loop (Fig. 6 b). Thus, our data 
demonstrate that the flexible CDR3 loop of the MAIT TCR 
can fine-tune its interactions and responsiveness to MR1 in 
an Ag-dependent manner.
B-F3-C1, C-C10, and C-A11 MAIT TCRs in complex with 
MR1–5-OP-RU (Table S2). The CDR3 loops of the B-B10 
and B-F3-C1 TCRs did not alter significantly between the 
MR1–Ac-6-FP and MR1–5-OP-RU complexes, regardless 
of whether the CDR3 loop directly contacted the Ag or not 
(unpublished data). However, the presence of the additional ribi-
tyl moiety caused moderate and marked conformational changes 
within the CDR3 loop of the C-A11 and C-C10 MAIT 
TCRs, respectively (Fig. 6, a and b). Regarding the C-A11 
MAIT TCR, the ribityl moiety, whereas maintaining the 
hydrogen bond with Glu98 nevertheless caused a reorienta-
tion of the Glu98 side chain to form a direct H-bond to 
Trp69 of MR1 (Fig. 6 a). The repositioning of Glu98 (2.0 Å 
displacement of O2) subsequently resulted in a remodeling 
Figure 4. MAIT TCR binding affinity and 
activation. (a) Relative binding of MAIT TCRs 
original WT (clone A-F7), B-B10, B-C10,  
C-A11, C-C10, B-G8, and B-F3-C1 against 
MR1–Ac-6-FP determined by SPR at 100 µM 
TCR. (b–k) Equilibrium binding curves for MAIT 
TCRs. (b) original WT (TRBV6-1, clone A-F7), 
(c) B-B10, (d) B-C10, (e) C-A11, (f) C-C10,  
(g) B-G8, (h) B-F3-C1, (i) #6 (TRBV6-4/
TRAJ33), (j) C-F7 (TRBV20), and (k) #4 
(TRAJ20) against MR1–5-OP-RU determined 
by SPR. Data are representative of the mean 
response for each TCR concentration and SEM 
in duplicate (n = 2). Dose response to  
synthetic rRL-6-CH2OH (l) or 5-A-RU (m)  
preincubated with C1R.MR1 cells by  
TRAV1-2-TRAJ33-TRBV6-1 MAIT TCR+ SKW3.
B-F3-C1, SKW3.B-G8, and SKW3.original WT 
(A-F7) or control TCR+ SKW3.LC13 cells. Data 
shows mean ± SEM fold of background MFI of 
CD69 expression for gated SKW3.TCR cells 
from 1 experiment (triplicate samples). These 
experiments were performed twice, yielding 
similar results.
 o
n
 O
ctober 13, 2015
jem.rupress.org
D
ow
nloaded from
 
Published July 21, 2014
JEM Vol. 211, No. 8 
Article
1593
published sequence data (clone C-F7; Tilloy et al., 1999) and 
described previously (Reantragoon et al., 2012) in complex 
with MR1–5-OP-RU (Table S3) and compared them to the 
TRBV6-1 ternary complex (Fig. 7, a–h).
The TRBV6-1 and TRBV6-4 TCRs docked similarly 
onto MR1–5-OP-RU (RMSD of 0.51 Å over all C atoms 
between the TCR V and MR1 1 and 2 domains; Fig. 7 a). 
The TRBV6-1 and TRBV6-4 chains share 83% sequence 
identity, with some of these differences located within the 
CDR loops and at the MAIT TCR-MR1 interface (Table 2). 
Differential V usage
In addition to the varied CDR3 usage, the MAIT TCR rep-
ertoire is characterized by differential TRBV usage, including 
the predominant utilization of the TRBV6-1, TRBV6-4, and 
TRBV20 genes in humans (Reantragoon et al., 2013). Accord-
ingly, we aimed to understand the molecular basis for how the 
differential TRBV usage can be accommodated while main-
taining MR1-Ag recognition. We determined the structures 
of a TRBV6-4 (clone described previously; Reantragoon et al., 
2012; MAIT TCR #6) and a TRBV20 TCR derived from 
Figure 5. Differential CDR3 usage and 
MAIT TCR-MR1-Ag recognition. Structural 
representation of the MR1 surface in white 
with Ac-6-FP bound, shown in green. MAIT 
TCR CDR3 loops for the 7 structures are 
indicated for (a) original WT (TRBV6-1, clone 
A-F7) in orange, (b) B-B10 in green, (c) C-A11 
in purple, (d) B-C10 in cyan, (e) B-G8 in 
salmon, (f) B-F3-C1 in magenta, and (g) C-C10 
in slate. Contacting residues between MR1 
and the CDR3 loops are shown in stick rep-
resentation with the contact surface on MR1 
shown according to the MR1 element type: 
carbon, orange; nitrogen, blue; oxygen, red; 
and sulfur, yellow. CDR boundaries are listed 
in Table 1.
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had the effect of lifting the -chain away from the MR1 in-
terface. Although the CDR2 loop was devoid of any large 
residues, thereby reducing the extent of MR1-mediated con-
tacts via this loop, the relative contribution of the CDR2 
was similar to TRBV6-1 (10 and 13%, respectively). In addi-
tion the relative contribution of the CDR3 to the BSA was 
similar between TRBV20 and TRBV6-1 (22% and 25%, re-
spectively). Despite this, the overall contact area was decreased 
in TRBV20 (1070 Å2). Accordingly, the TRBV20 chain ap-
peared nonideally disposed to interact with MR1, akin to 
TRBV6-4. However, in the TRBV20 ternary complex the 
CDR3 loop played a major role in interacting the MR1–5-
OP-RU akin to TRBV6-1 (BSA of 22 and 25%, respectively), 
thereby structurally compensating for the reduced inter-
actions from the germline encoded regions of the TCR 
-chain. Despite the differences in contact area between the 
complexes the Kdeq, determined by SPR (Table 2), for MR1–
5-OP-RU was comparable for each TCR (2.0, 2.7, and 
1.0 µM for TRBV6-1 [original WT, clone A-F7], TRBV6-4 
[#6], and TRBV20 [#4], respectively). This indicates how the 
MAIT TCR can readily tolerate some variations within the 
germline-encoded regions of the TCR -chain.
Atypical TRAJ gene usage
Although the invariant MAIT TCR -chain is character-
ized by TRAJ33 gene usage, we recently demonstrated that 
the TCR -chain could also consist of TRAV1-2 joined 
with the TRAJ20 or TRAJ12 gene segments (Reantragoon 
et al., 2013). Although the sequences differ between the 
TRAJ33, TRAJ12 and TRAJ20 regions, Tyr95 was con-
served (Table 1), thereby suggesting a conserved functional 
role in mediating contacts with the Ag. To formally establish 
this, we transduced genes encoding wild-type or mutant 
Y95F TRAJ20+ (#4) and three TRAJ12+, TRBV6-4+ MAIT 
TCRs (#1–3) differing in CDR3 into SKW3 cells, and 
compared their activation to that of TRAJ33+ MAIT TCR-
transduced SKW3 cells (all these TCRs were obtained from 
single cell sorted PBMCs reactive with MR1-Ag tetramer 
(Reantragoon et al., 2013; Fig. 8 a). SKW3 cell lines ex-
pressing TRAJ33+ (#5), TRAJ20+ (#4) and TRAJ12+ (#1–3) 
However, the CDR1 loop does not make appreciable con-
tacts with MR1 in either ternary complex, and thus the 
Asn28 → Arg28 substitution in TRBV6-4 does not im-
pact on MR1-Ag recognition (Fig. 7, c and d). The TRBV6-
4 CDR2 loop shows a more prominent contribution to the 
BSA at the MR1 interface than TRBV6-1 (BSA of 46 and 
26%, respectively), whereas the framework regions retain 
similar contributions between the two structures (BSA of 
19% for both complexes; Fig. 7, c and d). In contrast, the 
CDR3 loop showed a larger contribution to BSA for 
TRBV6-1 than TRBV6-4 (53 to 29%, respectively). The af-
finities of the TRBV6-1 and TRBV6-4 TCRs toward MR1–
5-OP-RU were similar (approximate Kdeq 2.0 µM and 2.7 
µM, respectively; Table 2). Thus, the TRBV6-4 TCR com-
pensates for the lower contribution of the CDR3 loop to 
the interface BSA by increasing the relative contribution of 
CDR2, to achieve a similar docking mode; nevertheless, the 
overall BSA was lower for TRBV6-4 than TRBV6-1 (1050 Å2 
and 1160 Å2, respectively).
Although the overall docking mode between the TRBV6-1 
and TRBV20+ TCRs onto MR1–5-OP-RU was similar 
(RMSD 0.79 Å over all C atoms between the TCR V and 
MR1 1 and 2 domains), greater variation in the interatomic 
contacts were observed due to the lower sequence identity 
between the respective TCR chains (35% sequence identity 
between V domains; Table 1 and Fig. 7, c and e). Whereas the 
TCR -chain of the TRBV20+ MAIT #4 TCR was situated 
very similarly atop MR1 when compared with the TRBV6-1+ 
original WT (A-F7) MAIT TCR, the TRBV20 -chain was 
juxtaposed differently to that of the TRBV6-1 -chain, re-
sulting in a 17-degree rotation away from the 1 helix of 
MR1 (Fig. 7 b). This difference can be attributed to differing 
V-V packing as well as differing V-MR1 contacts. The 
BSA contribution of the TRBV20 CDR1 loop was mar-
ginally higher than the TRBV6-1 complex (4 and 1%, re-
spectively; Fig. 7 e). Conversely, TRBV20 framework regions 
had reduced contributions compared with that of the 
TRBV6-1 and TRBV6-4 TCRs (BSA of 4, 9 and 8%, respec-
tively; Fig. 7 e). This was principally due to the TRBV20 lack-
ing Tyr48 (equivalent residue Thr49; Fig. 7, f and g), which 
Figure 6. Impact of different Ags on 
MAIT TCR-MR1-Ag recognition. Structural 
differences between the ternary complexes of 
MR1–Ac-6-FP-MAIT TCR (MR1: white, Ac-6-
FP: green, MAIT TCR: cyan) and MR1–5-OP-
RU-MAIT TCR (MR1: slate, 5-OP-RU: yellow, 
MAIT TCR: orange). Remodeling of the (a) C-A11 
and (b) C-C10 CDR3 loop between Ac-6-FP 
and 5-OP-RU complexes, with hydrogen 
bonds indicated in black dashed lines and vdw 
contacts in red dashed lines. CDR boundaries 
are listed in Table 1.
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indicating a commonality in function between the TRAJ12, 
TRAJ20, and TRAJ33 MAIT TCRs.
To directly investigate this, we determined the structure of 
a TRAJ20+ MAIT TCR in complex with MR1–5-OP-RU 
MAIT TCRs responded equivalently to the activating li-
gand containing synthetic rRL-6CH2OH in the presence of 
C1R.MR1 cells, and moreover, activation of all the mu-
tant Y95F SKW3 cell lines (Fig. 8 b) was impaired, thereby 
Figure 7. TRBV usage and MAIT TCR-
MR1-Ag recognition. Comparison of the 
MR1–5-OP-RU- MAIT TCR C-F7 (TRBV20), 
original WT (TRBV6-1, clone A-F7) and #6 
(TRBV6-4) complex variable domains and 
CDR loops in magenta, green and cyan, 
respectively. (a) Overlay of the CDR loops 
from the three complexes on the MR1–5-OP-
RU groove. (b) Comparison of relative angles 
for the V-domains of original WT (TRBV6-1, 
clone A-F7) and C-F7 (TRBV20) MAIT TCR 
structures. Footprints of the MAIT TCRs on the 
MR-5-OP-RU surface for (c) original WT 
(TRBV6-1, clone A-F7), (d) #6 (TRBV6-4), and 
(e) C-F7 (TRBV20). Contacting residues be-
tween MR1 and the (f) original WT (TRBV6-1, 
clone A-F7), (g) #6 (TRBV6-4), and (h) C-F7 
(TRBV20) CDR2 loops shown in stick repre-
sentation with the contact surface on MR1 
colored according to the MR1 element type: 
carbon, orange; nitrogen, blue; oxygen, red. 
CDR boundaries are listed in Table 1.
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TRAJ20 and TRAJ33 gene usage resulted in an altered interac-
tion network within the TCR /-chain junctional interface 
(Fig. 8 c), Tyr95 adopted a conserved binding mode with the 
ribityl tail of the 5-OP-RU ligand (Fig. 8 d). In addition SPR 
experiments revealed that the dissociation constant for TRAJ20 
TCR was comparable to TRAJ33 TCR (2.4 and 2.7 µM, 
(Table S3). The TRAJ20+ MAIT TCR-MR1-5-OP-RU com-
plex was very similar to the TRAJ33+ MAIT TCR-MR1–5-
OP-RU complexes with the general positions of the interactions 
being the same, thereby indicating that divergent TRAJ gene 
usage does not disrupt the consensus MAIT TCR-MR1 docking 
mode. Moreover, whereas the sequence differences between 
Figure 8. TRAJ usage and MAIT TCR  
recognition. (a) Dose response to synthetic 
rRL-6-CH2OH preincubated with C1R.MR1 cells 
by WT (a) or mutant Y95F (b) TRAV1-2-TRBV6-4 
TRAJ12+, TRAJ20+, and TRA33+ SKW3.MAIT. 
Data shows mean ± SEM fold of background 
MFI of CD69 expression for gated SKW3.TCR 
cells from one experiment (triplicate samples). 
These experiments were performed twice 
yielding similar results. Comparison of the 
MAIT TCR TRBV6-4 (c) TRAJ20 (#4) and (d) 
TRAJ33 (#6) MR1–5-OP-RU structures with 
MR1, 5-OP-RU, CDR3, and CDR3 loops 
shown in white, yellow, pale yellow, and  
orange, respectively. (e) Comparison of the 
positioning of CDR3 loops and Tyr95 for 
TRAJ20 (#4) and TRAJ33 (#6) in slate and pale 
yellow, respectively. Contacts between 
CDR3, CDR3, and 5-OP-RU are shown with 
dashed lines in black for hydrogen bonds and 
red for vdw contacts. CDR boundaries are 
listed in Table 1.
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(Gapin et al., 2013), the impact of the MAIT TCR CDR3 
loop appears to play a more subtle fine-tuning role, with the 
range of affinity values being much more clustered when com-
pared with the effect the NKT TCR’s CDR3 loop can have.
In describing a new ligand that competitively inhibits 
MAIT TCR recognition, Ac-6-FP, we demonstrate that the 
MR1-binding pocket has sufficient plasticity to accommodate 
this ligand, and simultaneously show how the ligand itself can 
markedly affect MR1 stability, which results in greater MR1 
cell-surface up-regulation and more potent inhibition. Interest-
ingly, the Ac-6-FP ligand can transmit its effects on MAIT TCR 
recognition indirectly, by altering the conformation of buried 
MR1 residues that subsequently affect surface-exposed MR1 
residues that directly contact the TCR. In this regard, this 
is analogous to how buried polymorphic MHC residues can 
impact on TCR recognition (Archbold et al., 2009; Gras 
et al., 2012) and some CD1d-restricted ligands can impact on 
F-pocket dynamics and hence TCR recognition (McCarthy 
et al., 2007; Li et al., 2010; Wun et al., 2011). This raises the 
possibility that weak agonists could selectively be stimulatory 
toward a subset of MAIT cells, with a key-determining factor 
being the CDR3 loop. Accordingly, MAIT TCR heteroge-
neity, while converging toward a consensus footprint on MR1, 
can nevertheless fine-tune MAIT TCR recognition.
In MHC-restricted immunity, altered peptide ligands (APLs) 
can exert markedly differing biological outcomes. Neverthe-
less, the TCR-MHC-APL docking modes of APL ranging 
from potent agonists to strong antagonists are very similar (Ding 
et al., 1999; Degano et al., 2000), thereby indicating that sub-
tle differences at the TCR-pMHC interfaces, and ensuing 
biophysical parameters of the TCR-pMHC interaction, play 
a major role in determining the antigenicity of a given pep-
tide (Huppa et al., 2010; Dushek and van der Merwe, 2014). 
The studies reported here are analogous to that of MHC- 
restricted APLs, in that the MAIT TCR-MR1-Ag docking 
mode between stimulatory and nonstimulatory MAIT cell 
antigens are very similar, yet markedly differing biological 
outcomes are elicited. The affinity of one MAIT TCR toward 
Ac-6-FP (approximate Kdeq 34 µM) was shown to be appre-
ciably higher than the remainder of the MAIT TCRs exam-
ined (Kdeq > 200 µM). Consistent with this, the MR1–Ac-6- 
FP tetramers have shown that the majority of MAIT cells 
do not bind with sufficiently high affinity to enable MAIT 
cell staining. Nevertheless, we are able to observe the MAIT 
TCR–MR1–Ac-6-FP interaction structurally, in a similar 
manner to which low-affinity TCR–pMHC interactions have 
been observed (Yin et al., 2012). Interestingly, the affinity of 
the nonstimulatory Tyr95Phe MAIT TCR mutant toward 
MR1–5-OP-RU was 30 µM, thereby indicating that the 
affinity threshold required for MAIT cell activation is below 
this value and that an 15-fold reduction in affinity can equate 
to a complete loss of activation. Moreover, a key feature be-
tween the stimulatory and nonstimulatory MAIT Ags is the 
direct contact between Tyr95 of the MAIT TCR and the 
MAIT Ag. Thus, our findings simultaneously provide insight 
into the factors that govern MAIT cell antigenicity.
respectively; Table 2). Thus, TRAJ20 and TRAJ12 gene het-
erogeneity is readily accommodated within the MAIT TCR–
MR1 binding axis.
DISCUSSION
MAIT cells, type I NKT cells, and germline-encoded my-
colyl lipid-reactive (GEM) cells are T cells that express distinct 
semiinvariant TCRs, which are restricted to MR1, CD1d, and 
CD1b, respectively (Rossjohn et al., 2012; Van Rhijn et al., 
2013). Here, the TCR -chain is generally fixed, whereas 
greater repertoire diversity is found within the TCR -chain. 
Within the type I NKT cell axis, it is established that the 
semiinvariant TCR acts like a pattern recognition receptor 
(Scott-Browne et al., 2007). Although the NKT TCR-CD1d 
docking mode is conserved, variations in TCR -chain usage 
can impact on the functional hierarchy of ligand recognition, 
in a mechanism that involves the CDR2 and CDR3 loops 
functionally collaborating to enable recognition (Mallevaey 
et al., 2009). Moreover, NKT TCR -chains appear to have a 
penchant for recognizing particular ligands, with the TCR 
-chain transmitting conformational changes to the invariant 
TCR -chain (Wun et al., 2011). Notably, NKT TCR auto-
reactivity is mediated via its CDR3 loop (Matulis et al., 
2010), which directly contacts CD1d, with the extent of au-
toreactivity being independent on the interactions with the 
CD1d-restricted Ag (Pellicci et al., 2011). Further, within the 
type I NKT system, variations within the TRAV and TRAJ 
usage is observed, with such differential TCR -chain usage 
correlating with differential Ag specificity within the consensus-
docking framework (Uldrich et al., 2011). Thus, although we 
have a growing understanding of type I NKT TCR recogni-
tion of CD1d, it is unclear whether these emerging generali-
ties would be mirrored by MAIT TCR-MR1 recognition, a 
vitamin B metabolite sensing system. Our data, presented here, 
provides fundamental insight into the similarities and dissimilari-
ties underpinning NKT TCR and MAIT TCR recognition.
We formally establish that, despite the varied TRAJ, TRBV, 
and CDR3 usage, the MAIT TCR-MR1-Ag docking mode 
is conserved, analogous to type I NKT TCRs recognizing 
CD1d–Ag complexes (Rossjohn et al., 2012). We show how 
differing TRAJ gene usage converges to similar MAIT TCR-
MR1-Ag recognition, with the key CDR3-encoded residue, 
Tyr95, making conserved interactions with the vitamin B 
metabolite (Reantragoon et al., 2012). Markedly dissimilar to 
NKT TCR recognition, however, is that the nongermline- 
encoded CDR3 loop of the MAIT TCR can directly contact 
the Ag, with the nature of the CDR3 contacts being dynami-
cally and directly modulated by the Ag itself. Moreover, the ex-
tent of CDR3 contacts mediated by the MAIT TCR is, on 
average, much greater than that for NKT TCR recognition, 
where for the most part the CDR3 loop plays a more periph-
eral role (Rossjohn et al., 2012). It also appears that, for the li-
gands tested, the CDR3 loop of the MAIT TCR impacts on 
MAIT recognition independently of the proximal CDR1 
and CDR2 loops. Further, while the CDR3 loop of the 
NKT TCR can have a huge influence on CD1d autoreactivity 
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MR1-K43A-5-OP-RU (loaded), MR1-K43A was incubated in TBS with a 
10 M excess of 5-OP-RU, prepared as described previously (Corbett et al., 
2014), for 4 h at room temperature in the dark. To separate 5-OP-RU–loaded 
MR1-K43A from unloaded MR1-K43A, complex of soluble MAIT TCR-
MR1-K43A-5-OP-RU was purified by gel filtration. MR1-K43A-5-OP-
RU was subsequently separated from MAIT TCR through the addition of 
excess 12H8 mAb specific for TCR (1.1:1.0 molar ratio 12H8 mAb to 
MAIT TCR in MR1-TCR complex), followed by gel filtration whereby 
MAIT TCR complexed with 12H8 mAb shifted to earlier elution volume as 
compared with MR1-K43A-5-OP-RU.
For the fluorescence-based thermal shift assay, triplicate samples consisting 
of 5 µg of MR1 and 2.5 µg of SYPRO Orange (Sigma-Aldrich) in 20 µl TBS 
were prepared on ice. Samples were heated from 25 to 95°C at a rate of 1°C/min 
using a Stratagene Mx3005P Real Time PCR machine. Thermal protein un-
folding caused unquenching of SYPRO Orange fluorescent signal, resulting in 
an increase of fluorescence signal (excitation at 492 nm, emission 610 nm). 
Emission signal at 610 nm was plotted against temperature and half maximum 
melt point (Tm50), at which 50% of the protein is unfolded, was determined 
upon base line correction, normalization, and nonlinear curve fit using the 
software GraphPad Prism. The experiment was performed three times.
Surface plasmon resonance. All surface plasmon resonance (SPR) experi-
ments were conducted in duplicate at 25°C on a BIAcore 3000 instrument 
using HBS buffer: 10 mM HEPES-HCl (pH 7.4), 150 mM NaCl, and 
0.005% surfactant P20 supplied by the manufacturer (GE Healthcare). Bio-
tinylated C-terminal cysteine-tagged-MR1-Ag (generated as described previ-
ously e.g., (Patel et al., 2013)) were immobilized on a SA-Chip with a surface 
density of 3000-4000 response units (RU). Various concentrations of MAIT 
TCRs (between 0.2 and 50 µM) were injected over the captured MR1-Ag 
at 10 µl/min. The final response was calculated by subtracting the response of 
a biotin-labeled flow cell alone from the TCR-MR1-Ag complex. The equi-
librium data were analyzed using GraphPad Prism to determine affinity con-
stants as the result of two independent experiments.
Crystallization, structure determination and analysis. Crystals of the 
soluble MAIT TCR-MR1-Ag complexes were obtained using the hanging 
drop vapor diffusion method. The MR1-2M-5-OP-RU, MR1-2M-Ac-6-
FP and MAIT TCRs were concentrated to between 2–4 mg/ml, mixed in a 
1:1 molar ratio, then 0.5 µl added to 0.5 µl of a precipitant solution consisting 
0.2 M sodium acetate, 0.1 M bis-tris propane with a pH ranging between 6 
and 6.5, and varying concentrations of PEG 3350 between 8–14% wt/vol 
depending on the complex. Crystals were observed after incubation at 20°C 
for 24 h in dark conditions. Cryoprotected before diffraction experiments by 
soaking in the crystallization condition modified with between 10–15% vol/
vol glycerol before cooling to 100K. Diffraction images were collected at the 
Australian Synchrotron MX2 beamline, diffracting in either a C2, P31 (MAIT 
TCR TRBV20 only) or P41212 (MAIT TCR TRAJ20 only) spacegroups. The 
data were processed using either XDS (Kabsch, 2010) or programs from the 
CCP4 Suite (Winn et al., 2011). The phase problem was solved by molecular 
replacement using PHASER (McCoy, 2007), using MR1 ternary complex 
(Protein Data Bank accession no. 4L4T; Patel et al., 2013) with CDR loops 
and ligands removed and using the Rfree reflection set from the model. The 
initial solution was refined in Phenix using simulated annealing refinement, 
with all subsequent refinement steps performed using BUSTER 2.10. Re-
straints for 5-OP-RU and Ac-6-FP were generated using the Grade Web 
Server, with model building performed in COOT using MolProbity for valida-
tion (Emsley and Cowtan, 2004). All molecular graphics were made with 
PyMOL. The buried surface area was calculated with Areaimol (Winn et al., 
2011) and RMSD values were calculated using the align function in PyMOL. 
Within the C2 crystal form there are two complexes per asymmetric unit, with 
these two complexes being very similar to each other. In relation to the Ag-
binding pocket of the structures reported here and previously (Patel et al., 
2013), minor perturbations around the side chains of E149 and Q153 were ob-
served, but this lies within coordinate error. Accordingly, unless explicitly stated, 
only one complex per asymmetric unit will be discussed in the manuscript.
MATERIALS AND METHODS
C1R.MR1, Jurkat.MAIT, and SKW3.MAIT cell lines. C1R APCs ex-
pressing MR1 (CIR.MR1) have previously been described (Reantragoon 
et al., 2012). For the generation of Jurkat.MAIT and SKW3.MAIT cells, full-
length TCR and TCR genes were cloned into a self-cleaving 2A peptide-
based (MSCV)-IRES-GFP (pMIG) vector (Szymczak et al., 2004) and stably 
transduced into TCR-deficient Jurkat clone 76 cells ( Jurkat76; Heemskerk 
et al., 2003), Jurkat RT3-T3.5 cells ( Jurkat; American Type Culture Collec-
tion no. T1B-153), or SKW3 cells (DSMZ accession code 53) using the ret-
roviral Murine Stem Cell Virus (MSCV) expression system. Transduced cell 
lines were FACS sorted based on fluorescence of GFP and flow cytometric 
staining for CD3, which co-expresses on the cell surface with TCR.
Activation of Jurkat.MAIT and SKW.MAIT cells. Jurkat or SKW3 cells 
(105) transduced with genes encoding MAIT TCR- and TCR-chain genes 
were tested for activation by co-incubation with compounds (synthetic rRL-6-
CH2OH or 5-A-RU, synthesized as described previously; Corbett et al., 2014) 
and C1R.MR1 cells (105) for 16 h. For inhibition, 6-FP, Ac-6-FP, or control 
pterins (Schircks Laboratories) were added to C1R.MR1 cells for 1 h before 
addition of Jurkat.MAIT cells and 0.02 µM synthetic rRL-6-CH2OH. Cells 
were subsequently stained with PE-conjugated anti-CD3 (BD), and APC-
conjugated anti-CD69 (BD) mAbs for 30 min on ice, before analysis of 
CD69 surface expression by flow cytometry. Activation of Jurkat.MAIT or 
SKW.MAIT cells was measured by an increase in surface CD69 expression.
Jurkat76 cells (105) transduced with genes encoding the WT original 
(clone A-F7) MAIT TCR - and -chain genes were co-incubated with 
compounds (6-FP, Ac-6-FP; 5-OP-RU; Schircks Laboratories) and C1R.
MR1 cells (105) in 200 µl media for 21 h. IL-2 production was measured as 
a mean of Jurkat76.MAIT activation in ELISA (BD OptEIA kit) using 100 µl 
of supernatant, frozen/thawed to kill cells. In brief, IL-2 was assayed with 
biotinylated anti–IL-2 mAb and o-Phenylenediamine dihydrochloride 
(OPD; Sigma-Aldrich) substrate conversion by HRP-Streptavidin detected 
at 492 nm emission.
Detection of up-regulation of MR1 on the cell surface. C1R.MR1 
cells (105) were incubated for 2, 4, or 24 h with compounds. After this, cells 
were washed and stained with MR1-specific mAb 26.5 on ice for 30 min, 
followed by PE-conjugated anti–mouse-IgG on ice for 30 min before analy-
sis. For the comparison of C1R and C1R.MR1 expression levels over time, 
cells (2 × 105) were incubated for 1, 2, 4, 12, or 24 h with 10 µM 6-FP or Ac-
6-FP, or no treatment (media alone). Cells were then washed and stained with 
biotin-conjugated 26.5 mAb, followed by PE-conjugated streptavidin.
Generation of soluble MR1-ligand, MR1 K43A (empty), C-terminal 
cysteine-tagged-MR1/ligand, MR1 tetramers, and soluble MAIT TCRs. 
Genes were expressed in E. coli inclusion bodies, refolded and purified as 
described previously (Patel et al., 2013). Tetramers were generated as de-
scribed previously (Corbett et al., 2014) and prepared simultaneously.
Tetramer staining of PBMCs. PBMCs were isolated from whole blood of 
healthy donors (authorized by the Australian Red Blood Cross Service Ma-
terial Supply Agreement with the University of Melbourne) as described 
previously (Reantragoon et al., 2013). Approximately 1.2 × 106 human 
PBMCs were stained with live/dead discriminator (Live/Dead Fixable Aqua 
Dead Cell Stain kit; Invitrogen) PE-labeled, human tetrameric, MR1–5-OP-
RU, MR1-6-FP or MR1–Ac-6-FP at 5 µg/ml, anti-CD3-Alexa Fluor 700 
(BD), and anti-CD161-PE-Cy7 (BioLegend) mAb for 30 min on ice in the 
dark. Cells were then washed three times with wash buffer (2% fetal calf 
serum in PBS) and resuspended in fixing solution (2.1% glucose and 1% 
paraformaldehyde in PBS). Data were acquired using an LSR Fortessa (BD) 
and analyzed using FlowJo software.
Thermostability of soluble MR1 by fluorescence-based thermal 
shift assay. Soluble MR1-6-FP, MR1–Ac-6-FP, MR1–5-OP-RU and 
MR1-K43A (empty) were purified by gel filtration before the assay. To generate 
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